14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 136 days ( -71.16 % )
Last Price $15.25 0 %
High/ Low $15.25 - $15.25 0%
Chg 7 Days N/A $15.25 $15.25
Chg 30 Days N/A $15.25 $15.25
Chg 12 mos 134.62 % $6.50 $15.25
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 126.91 % Width: 59.26 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $28.64 - $45.61 87.78 % - 199.06 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Oct 27, 2022 - 78 days
Long MA avg 12 mos Buy Aug 04, 2022 - 137 days
Short/Long MA avg 12 mos Buy Aug 05, 2022 - 136 days
Pivot Short Sell Feb 16, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Aerie Pharmaceuticals

Aerie Pharmaceuticals Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily ... AERI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT